Genentech Will Use Dharmacon s RNAi Technology for Drug Discovery

Jan 21, 2005

NEW YORK, Jan. 21 (GenomeWeb News) - Genentech will use Dharmacon's RNAi technology in its drug-discovery research, Dharmacon said today.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.